Concerns Grow as NHS Prescribes Nicotine to Teenagers

Feb.21.2025
Concerns Grow as NHS Prescribes Nicotine to Teenagers
Scottish NHS prescribes nicotine patches and gum for 13-year-olds amid concern over youth e-cigarette use, with over 1000 prescriptions issued.

According to a report by Daily Mail on February 15th, the National Health Service in Scotland (NHS) is prescribing nicotine patches and gum to teenagers as young as 13 due to concerns about the increasing number of children using e-cigarettes.


In the past two years, doctors have prescribed over 1000 treatments for underage individuals addicted to nicotine. In 2018, the number of adolescents aged 16 to 18 receiving smoking cessation therapy increased by nearly 60%.


Dr. Sandesh Gulhane, the Conservative Party spokesperson on health matters in Scotland, expressed deep concern over 13-year-olds being prescribed nicotine replacement products. He criticized the Scottish National Party for their lack of action in addressing the issue of e-cigarette addiction, which has led to thousands of children becoming addicted. He called on the government to ensure that the upcoming law banning disposable e-cigarettes is effectively enforced.


Data provided to the Sunday Mail by the Scottish Department of Public Health shows that in 2023, 166 children aged 13 to 15 were prescribed nicotine replacement therapy, while 289 prescriptions were given to teenagers aged 16 to 18. In 2024, 116 children aged 13 to 15 received prescriptions, while 461 teenagers aged 16 to 18 were prescribed nicotine replacement products, representing a 59% increase from 2023.


Currently, NHS Scotland provides seven nicotine replacement therapies including gum, patches, lozenges, and sprays. These therapies work by gradually reducing addiction through therapeutic nicotine doses that do not contain harmful chemicals found in cigarettes or e-cigarettes.


A spokesperson for the Scottish government stated, "Nicotine replacement therapy is one of the most effective methods for managing nicotine dependence, approved for use by those aged 12 and over. We are actively addressing the issues of youth smoking and e-cigarettes, and working collaboratively with the UK government and other regions to promote the Tobacco and E-Cigarette Act, which will gradually increase the age for product sales and create a smoke-free generation.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
    Shenzhen Tobacco Monopoly Bureau Moves to Advance E-Cigarette Regulatory System 2.0
Shenzhen Tobacco Monopoly Bureau Moves to Advance E-Cigarette Regulatory System 2.0
The Shenzhen Tobacco Monopoly Bureau recently held the city’s 2026 e-cigarette regulation work conference to implement higher-level meeting requirements, review the city’s e-cigarette regulatory work in 2025 and during the 14th Five-Year Plan period, assess the current situation, and deploy the rollout of E-cigarette Regulatory System 2.0 across Shenzhen’s tobacco commercial system.
Apr.28 by 2FIRSTS.ai
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai